Literature DB >> 3193513

An evaluation of serial digital rectal examinations in screening for prostate cancer.

E J Mueller1, T W Crain, I M Thompson, F R Rodriguez.   

Abstract

The purpose of this review is to test the hypothesis that serial digital rectal examinations of the prostate lead to detection of prostate cancer at an earlier and more curable stage. The clinic records of 4,843 patients between 40 and 79 years old seen at the Brooke Army Medical Center prostate cancer screening clinic between January 1979 and September 1985 were reviewed. Of the patients with palpable nodules 122 were found on biopsy to have adenocarcinoma of the prostate. We compared the clinical and, when possible, pathological stage of disease diagnosed at the initial clinical visit to those from patients who had prior normal digital rectal examinations at the screening clinic and who were followed at our clinic. There was a numerically striking difference in the percentage of patients in each group with clinical as well as pathological stage B cancer. Due to the small number of patients in each group these differences were not statistically significant.

Entities:  

Mesh:

Year:  1988        PMID: 3193513     DOI: 10.1016/s0022-5347(17)42069-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer.

Authors:  Xiaojing Bai; Yumei Jiang; Xinwei Zhang; Meiyu Wang; Juanhua Tian; Lijun Mu; Yuefeng Du
Journal:  Cancer Manag Res       Date:  2020-08-04       Impact factor: 3.989

2.  Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer.

Authors:  W H Cooner
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

3.  Screening for prostate cancer. How can patients give informed consent?

Authors:  K G Marshall
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

Review 4.  Screening for carcinoma of the prostate: efficacy of available screening tests.

Authors:  I M Thompson; W R Fair
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.